about
Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathyHemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inflammatory targets of therapy in sickle cell disease.
@ast
Inflammatory targets of therapy in sickle cell disease.
@en
type
label
Inflammatory targets of therapy in sickle cell disease.
@ast
Inflammatory targets of therapy in sickle cell disease.
@en
prefLabel
Inflammatory targets of therapy in sickle cell disease.
@ast
Inflammatory targets of therapy in sickle cell disease.
@en
P2860
P50
P1476
Inflammatory targets of therapy in sickle cell disease
@en
P2093
Chibueze A Ihunnah
P2860
P304
P356
10.1016/J.TRSL.2015.07.001
P577
2015-07-11T00:00:00Z